Inhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears.

  • Richard Long, Richard Jones, +4 authors Bruce Light
  • Published 2005 in Antimicrobial agents and chemotherapy
Endogenous nitric oxide (NO) has antimycobacterial properties. We tested the hypothesis that exogenous (inhaled) NO can be safely delivered and can accelerate airway disinfection for pulmonary tuberculosis patients treated with standard therapy. Exogenous NO administered at 80 ppm for 72 h can be safely delivered but does not accelerate airway disinfection. 

3 Figures & Tables